| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/28/2009 | CN101353383A Water-soluble yeast beta-dextran and preparation thereof |
| 01/28/2009 | CN101353382A Extraction method of antioxidative active Cordyceps sinensis polysaccharide |
| 01/28/2009 | CN101353380A Jellyfish origin immune activity enhanced collagen peptide, preparation and use thereof |
| 01/28/2009 | CN101353367A Refining method of fluticasone propionate |
| 01/28/2009 | CN101352532A Six-grain liquor for stimulating appetite and lengthening life |
| 01/28/2009 | CN101352511A Medicated health-caring wine |
| 01/28/2009 | CN101352510A Deer blood wine for improving immunity of body and preparation method thereof |
| 01/28/2009 | CN101352498A Formulation for reducing medicine toxicity damage and improving immunity and regulating blood sugar and preparation method thereof |
| 01/28/2009 | CN101352478A Quality control method of ginseng and astragalus injection for strengthening body |
| 01/28/2009 | CN101352431A Medicament for resisting allergic diseases |
| 01/28/2009 | CN101352416A Luteolin solution composition |
| 01/28/2009 | CN101352365A Positioner for fixing micro organs |
| 01/28/2009 | CN101352234A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 01/28/2009 | CN100455600C Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 01/28/2009 | CN100455599C Gene recombinant antibody and its fragment |
| 01/28/2009 | CN100455598C Antibody of anti human CD20 from human resources functionally, and application |
| 01/28/2009 | CN100455596C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/28/2009 | CN100455571C Kukoline salt compounds and its preparation method |
| 01/28/2009 | CN100455564C Histone de-acetylase inhibitor, preparation and application of pharmaceutical preparations of the same |
| 01/28/2009 | CN100455328C Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 01/28/2009 | CN100455300C Compound wild kiwi tablet and its preparing method |
| 01/28/2009 | CN100455294C Process for preparing chick embryo element |
| 01/28/2009 | CN100455290C Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 01/28/2009 | CN100455287C Formulations |
| 01/28/2009 | CN100455283C Medicine containing acarnine compound as active component |
| 01/28/2009 | CN100455237C Pillow with health-care function and its preparing process |
| 01/27/2009 | US7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482362 Substituted-4-quinolones |
| 01/27/2009 | US7482355 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482137 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7482000 Point mutations; immunology |
| 01/27/2009 | CA2416403C A medicinal aerosol formulation |
| 01/27/2009 | CA2391871C Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 01/27/2009 | CA2388646C Methods and compositions utilizing quinazolinones |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2225278C Recombinant mva virus, and the use thereof |
| 01/27/2009 | CA2186747C Interleukin-15 |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/25/2009 | CA2597865A1 Compositions for therapeutic treatment of hpv related conditions and diseases |
| 01/22/2009 | WO2009011889A2 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 01/22/2009 | WO2009010769A1 Pharmaceutical compositions comprising nucleic acids encoding constitutively active toll-like receptors. |
| 01/22/2009 | WO2009010488A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | WO2009010480A1 1-{2-[(diphenyl)amino]-ethyl}-piperidine-4-carboxylic acid benzylamide derivatives and related compounds as ccr5 agonists for the treatment of immune and inflammatory diseases |
| 01/22/2009 | WO2009010477A1 Piperidine-4-acetic acid derivatives and their use |
| 01/22/2009 | WO2009010021A1 Immunostimulatory activity of trilobolide and method of preparation thereof |
| 01/22/2009 | WO2009009892A1 Engineered scfv against bovine herpes virus type i |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009882A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009881A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009876A1 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 01/22/2009 | WO2008076447A3 Treatments of therapy-resistant diseases comprising drug combinations |
| 01/22/2009 | US20090023807 Treatment of Cytokine Dysregulation by Using Sn-2 Gamma-Linolenoyl, Gamma-Diho-Molinolenoyl or Arachidonoyl Patty Acid Glycerol Monoesters |
| 01/22/2009 | US20090023805 Method of administration |
| 01/22/2009 | US20090023800 Cannabinoid receptor modulator |
| 01/22/2009 | US20090023795 Kinase Inhibitors And Methods Of Use Thereof |
| 01/22/2009 | US20090023788 Treatment of CRTH2-mediated diseases and conditions |
| 01/22/2009 | US20090023774 Pyridine analogs as C5A antagonists |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023761 Heterocyclic compounds and their uses |
| 01/22/2009 | US20090023742 Thiazolones for use as pi3 kinase inhibitors |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023724 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 01/22/2009 | US20090023722 Amide substituted imidazoquinolines |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023662 recognize extracellular structures of G protein-coupled receptors; for treating humoral kidney rejection |
| 01/22/2009 | US20090023660 Novel Hemopoietin Receptor Protein, NR12 |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023630 Methods and Means for Use in Diagnostics and Treatment of Diabetes |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023216 Double-Stranded Oligonucleotides |
| 01/22/2009 | US20090023152 Transcription factor MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances |
| 01/22/2009 | US20090022799 Compositions that contain beta-glucan to be used for the prevention and treatment of disease and methods for their use |
| 01/22/2009 | US20090022762 Polyvalent influenza virus-like particle (VLP) compositions |
| 01/22/2009 | US20090022752 Recovering the protein expressed by open reading frame 2 from porcine circovirus type 2; provide immunogenic composition that comprises PCV2 ORF2 proteins and that are highly stable over a period of 24 months; lung lesions, nasal shedding, cough, diarrhea, |
| 01/22/2009 | US20090022751 Pcv2 immunogenic compositions and methods of producing such compositions |
| 01/22/2009 | US20090022750 Pcv2 immunogenic compositions and methods of producing such compositions |
| 01/22/2009 | US20090022749 Recovering the protein expressed by open reading frame 2 from porcine circovirus type 2; provide immunogenic composition that comprises PCV2 ORF2 proteins and that are highly stable over a period of 24 months |
| 01/22/2009 | US20090022747 B7-h3 and b7-h4, novel immunoregulatory molecules |
| 01/22/2009 | US20090022746 Complexes for transferring nucleic acids into cells |
| 01/22/2009 | US20090022743 Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells |
| 01/22/2009 | US20090022739 MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR ALPHA (tnf-ALPHA) AND TREATING HUMAN DISEASE OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-ALPHA |
| 01/22/2009 | US20090022738 Multispecific deimmunized CD3-binders |
| 01/22/2009 | US20090022734 Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022719 Preventive and/or therapeutic method for systemic lupus erythematosus comprising anti-IL-6 receptor antibody administration |